RISW2025
Back to all people

Zheng Li

Novartis Pharmaceuticals
1 appearance in the program

Sessions & presentations

TL04-06 Roundtable Discussions
Presentation: TL05: Considerations of Dose Optimization in Oncology Drug Development
Roundtable · Thu, Sep 25 , 11:45 AM
Presenting Leader
↑